Introduction
The surgical treatment of aortic valve endocarditis remains a major challenge in cardiac surgery (1).
Even though much progress has been made in terms of management and pharmacological treatment, the ideal prosthesis to use in these cases has not been found yet.
Some surgical groups started using the Sorin Perceval sutureless bioprosthetic valve even in complicated scenarios such as aortic endocarditis (2-5).
Up to now, only a few small series have been reported in the literature, and no data are available regarding the mid-and long-term follow-up of these patients.